Abstract: Herbal compositions derived from Kenyan plants are provided for the treatment of HIV and other infectious diseases. The herbal compositions can include the extracts of up to 14 plants, including the root of Dovyalis abyssinica and Clutia robusta. Also provided are methods for extracting alkaloids and other compounds from the plants. Also provided are methods of treating a subject having an infectious disease, particularly HIV.

Abstract: A topical skin care product is provided that contains therapeutic concentrations of turmeric and other constituents which is colorless upon application to the skin. The product can be used for cosmetic, protective, and healing purposes without staining skin or clothing yellow.

Abstract: A dietary supplement composition comprising a therapeutically effective amount of at least one sirt 1 activating agent, a therapeutically effective amount of at least one Qi activating agent, and an therapeutically effective amount of at least one adaptogen is disclosed. An optional herbal treatment for stress-related deep wrinkles comprises chronic oral administration for at least two weeks of a beverage containing an effective amount of a valerian root extract sufficient to provide a desired reduction in the appearance of the deep wrinkles. A photoprotective agent may also be included. Also included are a microcirculation increasing agent. Also optional are an herbal toner and topical cellulite product.

Abstract: The present invention relates to a medical herb composition for reducing shedding of mammal hair and a method for preparing the same. The medical herb composition comprises: a first herb material selected from the group consisting of Ginseng Radix, Astragali Radix, Batatatis Rhizoma, Zizyphi Fructus, Tremella, Codonopsis Pilosula, or the combination thereof; a second herb material selected from the group consisting of Angelicae Radix, Rehmanniae Preparata Radix, Longanae Arillus, Lycii Fructus, Paeonia lactiflora, or the combination thereof; and a third herb material selected from the group consisting of Rehmanniae Radix, Ligustrum Lucidum, Eclipta prostrata, Dendrobium hancockii, Polygonum multiflorun (i.e. Dioscorea bulbifera or Cynanchum wilfordi), or the combination thereof. The medical herb composition of the present invention can reduce shedding of mammal hair, promote the growth of hair, and also can efficiently improve vitality, skin condition, and complexion.

Abstract: A fluid konjak material, which can be mixed with any other edible material uniformly at a high concentration while sufficiently keeping the gelling power and the biological effect intrinsic to konjak mannan, is provided by swelling and dissolving konjak flour in water, treating the resultant with alkali at a pH of at least 10, lowering the pH to less than 8, heating the composition with forced stirring and enzymatically treating the forcedly-stirred composition.

Abstract: A process for producing porous polymer masterbatch having anti-bacterial and odor eliminating functions, wherein said fiber contains materials such as porous natural mineral kieselguhr or active carbon, can absorb and eliminate odor such as stink of sweat and the like discharged from the human body, has functions of sterilization, anti-bacterial, anti-mold, and the like. Pores of the natural mineral kieselguhr or active carbon contain organic Chinese herbal medicine and inorganic anti-bacterial minerals, wherein all of such organic Chinese herbal medicine and inorganic anti-bacterial minerals have functions of anti-bacterial, anti-fungal and the like, can eliminate effectively odor or reduce substantially stink, and can be applied extensively on various fabrics, clothes and ornaments or other goods.

Abstract: An extract of the family Dioscoreaceae useful for preventing or treating the peripheral neuropathy; and a pharmaceutical composition or food composition comprising the extract are provided. In addition, a pharmaceutical composition or food composition useful for preventing or treating the peripheral neuropathy comprising a compound isolated from the extract of the family Dioscoreaceae is provided.

Abstract: The invention relates to the cosmetic use of at least one epidermal differentiation activator for combating the effects of electromagnetic waves on the skin. The invention also relates to a cosmetic treatment process comprising the application, to the skin or the integuments, of a cosmetic composition comprising at least one epidermal differentiation activator for combating the effects of electromagnetic waves on the skin.

Abstract: This invention describes a comprehensive nutraceutical designed to antagonize major mitigating factors to the degenerative process associated with Parkinson's disease. The formulation is comprised of a primary base of pyruvate, succinate, ?-Ketoglutarate and/or oxaloacetate, niacin/NADH, fruit extracts, anthocyanins, further combined with specific macro/micronutrients, trace elements, amino acids, flavonoids and concentrated plant sources. The nutraceutical contains all natural substances that should mitigate many of the neurodegenerative processes known to be associated with PD. Mechanisms addressed are to prevent the loss of ATP/by 1-methyl-4-phenylpyridinium rotenone, scavenge hydrogen peroxide/O2.

Abstract: The present invention relates to methods for preparing a pharmaceutical composition for treating diabetes mellitus and the pharmaceutical composition prepared by the methods. The pharmaceutical composition of the present invention comprises extracts of the following crude drugs: 5-40 weight parts of Radix Trichosanthis (Tianhuafen), 10-30 weight parts of Radix Bupleuri (Chaihu), 3-15 weight parts of Fructus Aurantii Immaturus (Zhishi), 1-6 weight parts of Radix et Rhizoma Rhei (Dahuang), 1-12 weight parts of Rhizoma Pinelliae (Banxia), 3-15 weight parts of Radix Scutellariae (Huangqin), 1-12 weight parts of Rhizoma Coptidis (Huanglian), 3-15 weight parts of Radix Paeoniae Alba (Baishao) and 5-20 weight parts of Fructus Mume (Wumei), and optionally comprises pharmaceutically acceptable excipient. Also, the pharmaceutical composition of the present invention can further comprise Fructus Crataegi (Shanzha). Additionally, the present invention discloses four methods for preparing the pharmaceutical composition.

Abstract: A nutraceutical substance comprising Adansonia digitata (Baobab), Borojoa patinoi (Borojo), Cyclanthera Pedata (Caigua) and Aframomum melegueta (Grains of Paradise). In some embodiments, the whole fruit of these plants may be used. In other embodiments, roots bark, saps, roots or seeds from these plants may be used. The substance may be dried, powderized, and packaged for use directly, or processed into a pill or digestible capsule form. In other embodiments, the substance may be used as brew, water extract, alcohol extract, or pulp mixture. The substance is intended for ingestion by a human user, and may be useful to promote well-being, provide nutritional value, and aid in preventative health management. Cosmeceutical and hair care formulations employing these ingredients are also disclosed.

Abstract: The present invention relates to pharmaceutical compositions for treating virus infections and/or diseases caused thereby comprising 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide optionally combined with at least one additional therapeutic agent.

Abstract: A nutritional supplement for inhibiting sensorineural hearing loss includes from about 0.25 to about 6.0 wt. % thiamin, from about 0.1 to about 10 wt. % pyridoxiyl-5-phosphate, from about 0.01 to about 10 wt. % folic acid, from about 0.025 to about 4.0 wt. % hydroxycobalamin, from about 1 to about 7 wt. % magnesium, from about 0.25 to about 6.0 wt. % zinc, from about 0.001 to about 0.02 wt. % selenium, from about 0.1 to about 10 wt. % manganese, from about 5 to about 50 wt. % ginger root P.E. 4:1, from about 5 to about 40 wt. % citrus bioflavonoids, from about 2.5 to about 40 wt. % 1-cystine, from about 5 to about 40 wt. % n-acetlyl-l-carnitine, from about 1 to about 40 wt. % alpha lipoic acid, from about 1 to about 40 wt. % coenzyme Q10, from about 1 to about 40 wt. % green tea extract, and from about 1 to about 60 wt. % resveratrol.

Abstract: The present invention relates to an alcohol extract of ogalpi, erectile dysfunction improving health food and a treating agent containing the same, more precisely, an alcohol extract of ogalpi having an effect of improving erectile dysfunction, erectile dysfunction improving health food and an erectile dysfunction treating agent containing the same. The alcohol extract of ogalpi of the present invention has a promoting effect of penile erectility, so that it can be effectively used for the improvement of erectile dysfunction.

Abstract: A natural oriental medicinal composition for the promotion of hair growth is provided. The oriental medicinal composition includes a black bean extract, a tangerine extract, a potato extract, a pine needle extract and a quartzite powder. Since the oriental medicinal composition includes crude drugs extracted from natural substances that can prevent hair loss, it is effective for hair growth and has ensured biostability. Particularly, the oriental medicinal composition allows newborn hair to grow in the form of stiff hair.

Abstract: The present invention discloses bio-efficacy and bio-availability enhancing composition comprising, an effective amount of stevia compound selected from raw powder or extract, or fraction(s) or compound(s) or combinations thereof derived from the whole plant or plant parts of genus Stevia, preferably leaves of Stevia rebaudiana for enhancing the bio-availability and bio-efficacy of therapeutic agents, cosmetic agents, supplements, food ingredients and beverages selected from but not limited to pharmaceutical drugs, nutrients (micro and macro nutrients), vitamins, minerals, Proteins, amino acids, enzymes, nutraceuticals, herbal drugs/products and antioxidants.

Abstract: Methods of extracting from a part of a variety of the species Aristolochia Longa pomer, a biologically active extract, are disclosed. Methods of reducing cell growth in a subject and inducing apoptosis in a cell are also disclosed.

Abstract: Disclosed are novel preparations of Actinidia, and particularly species of hardy kiwifruit, as well as compositions comprising the same. Also disclosed is the use of these preparations of Actinidia to prevent and/or treat a variety of diseases in which regulation of the immune response is effective, including both allergic and non-allergic inflammatory disease, viral infection, and cancer. Methods related to making and using these compositions are also described.

Abstract: A composition for affecting physiological sleep disorders comprising a therapeutically effective amount of Baiziren extract or any of its derivatives, and a pharmaceutically acceptable carrier. The composition may additionally comprise a therapeutically effective amount of at least one of a Suanzaoren extract and a Yuanzhi extract, or mixtures thereof.

Abstract: The present invention relates to an anti-allergic agent, an anti-allergic food additive and an anti-allergic food each containing both ground lotus and/or extract and a lactic acid bacterium. The anti-allergic agent, anti-allergic food additive and anti-allergic food each contain both ground lotus and/or extract and a lactic acid bacterium as the active ingredients thereby enabling amelioration and treatment of allergic diseases including pollinosis, bronchial asthma and atopic dermatitis.

Abstract: The invention provides a method of treating a subject afflicted with a disease associated with demyelination of the central nervous system comprising administering to the subject a therapeutically effective amount of any of a composition containing Tripterygium wilfordii Hook F. root extract or components thereof and a pharmaceutically effective carrier in an amount effective to treat the subject.

Abstract: A solid pharmaceutical dosage form that is safeguarded against abuse, comprising at least one active substance that is susceptible to abuse and at least one emetic that is spatially separate from the at least one active substance. The active substance or substances are present in the form of at least one sub-unit (a), and the at least one emetic is present in the form of at least one sub-unit (b), and the emetic from sub-unit (b) is not activated in the body if the dosage form has been correctly administered as prescribed.

Abstract: This invention provides a method for identifying a composition of Cinnamomi and Poria. This invention further provides a composition comprising: Ramulus Cinnamomi, Poria Cortex, Moutan Radicis, Radix Paeonize Alba, and Semen Persicae. This invention provides various uses of these compositions.

Abstract: A compound derived from an extract of vegetative tissue of plants of the Genus Shortia demonstrates antitcarcinogenic potential by inhibiting the growth and development formation of tumors in living tissue in response to an organism known to cause the initiation of tumors in living tissue and by reducing mutation rates in living tissues exposed to a known mutagen.

Abstract: This invention relates to a use of hederagenin 3-O-?-L-rhamnopyranosyl((1?2)-[?-D-glucopyranosyl(1?4)]-?-L-arabinopyranoside or a Pulsatillae radix extract containing the same as a therapeutic agent for solid tumors. Also, this invention relates to a method of preparing a therapeutic agent for solid tumors by using hederagenin 3-0-?-L-rhamnopyranosyl(1?2)-[?-D-glucopyranosyl(1?4)]-?-L-arabinopyranoside, or a method of treating a subject suffering from solid tumors, comprising administering to the subject a therapeutically effective dose of hederagenin 3-0-?-L-rhamnopyranosyl(1?2)-[?-D-glucopyranosyl(1?4)]-?-L-arabinopyranoside.

Abstract: Compositions are disclosed which have as a component thereof an inhibitor of the enzymatic production of 3-deoxyglucosone (3DG) from fructoselysine and/or an inactivator of 3DG, and which are useful for the treatment or prophylaxis of a condition or disease state that is alleviated by inhibiting such 3DG production. Methods of using such compositions, e.g., for improving the appearance, texture and/or elasticity of aging skin, are also disclosed.

Abstract: The present invention relates to a method of cosmetic treatment for combating the effects of skin ageing and to novel cosmetic compositions which are particularly suitable for carrying it out. According to the invention, at least one agent for promoting the adhesion of the keratinocytes of the epidermal basal layer to the dermo-epidermal junction, especially to the collagen IV of said junction, such as, in particular, a divalent metal salt or complex, preferably magnesium aspartate or magnesium chloride, is used, optionally in association with a stimulant of collagen IV synthesis and/or a stimulant of collagen VII synthesis.

Abstract: The present invention relates to a process for the extraction of plants, especially roots, of the plant genus Pelargonium, characterised in that the plants are extracted with an ethanol-free solvent or a mixture of ethanol-free solvents, selected from the group consisting of water and at least one monohydric alcohol with at least three carbon atoms, water and at least one polyhydric alcohol, water and at least one inorganic, organic, monoprotic or polyprotic acid or a derivative thereof, at least one vegetable oil and carbon dioxide.

Abstract: A novel exfoliating compound and method for treating acne without an irritating cleanser. The compound includes a first subcompound formed from a clay based substance and a second subcompound formed an exfoliating substance selected from the group consisting of crystals, beads, polyethylene, nuts, natural rough products, corundum crystals, crushed almond shells and crushed apricot kernels.

Abstract: The invention relates to compositions capable of modulating visceral sensation and/or gastrointestinal activity obtained from botanical sources. More specifically, the invention relates to compositions comprising an extract product of an Asclepias plant, and methods of modulating visceral sensation and/or gastrointestinal activity in an individual using same.

Abstract: The present invention relates to cosmetic and dermatological preparations, in particular skincare, cosmetic and dermatological emulsions containing an additive from the baobab plant (monkey bread tree).

Abstract: A method for removing pests from harvested vegetables has steps of extracting a first portion of harvested vegetables to obtain a vegetable cleanser, and cleaning a second portion of harvested vegetables with the vegetable cleanser, such that pests residing on the second portion of harvested vegetables are removed from the second portion of harvested vegetables, wherein the first portion of harvested vegetables and the second portion of harvested vegetables independently contain vegetables selected from the group consisting of vegetables belonging to the families of Cruciferae, Compositae, Chenopodiaceae and Amaranthaceae. The aforementioned method is effective at removing pests from harvested vegetables and satisfies urgent needs to reduce use of chemical pesticides.

Abstract: The invention provides a process for the production of a substance or composition for the treatment, by therapy or prophylaxis, of parasitic infections, in particular malarial infections such as Plasmodium falciparum infections, of the human or animal body. The process comprises extracting the substance or composition from roots of the plant species Dicoma anomala, by an extraction using an organic solvent to obtain a liquid extract containing the substance or composition and removing the solvent from the liquid extract to leave a dried extract containing the substance or composition. The invention extends also to the use of the substance or composition in the manufacture of a medicament or preparation for such treatment of infections; to a substance or composition for use in such treatment of said infections; to compounds for use in such treatment of said infections; and to a method of treating said infections using such compounds.

Abstract: The invention relates to the use of a plant extract of a plant of the Limnophila genus, in particular an extract of the plant species Limnophila conferta, as a cosmetic agent or as an active agent in cosmetic compositions.

Abstract: Disclosed are an extract from traditional Chinese herbal medicine Trichosanthes with the activity of increasing globin gene expression and a composition comprising the extract. A method for preparing the extract and use thereof in treating disorders related to globing gene expression is also provided.

Abstract: The present invention refers to compositions of atomized or lyophilized extracts of selected maca hypocotyls of the red and black variety and atomized or lyophilized parts of the yacon plant selected from leaves and roots. The invention also refers to the methods to prepare such compositions using aqueous or hydroalcoholic extraction processes. Likewise, as novel element of the maca hypocotyls extraction process is the selection of the batches of maca hypocotyls having a pH of less than 5.5, which have better biological activity than those with a greater pH. The compositions of the invention are useful in the treatment of different conditions and diseases.

Abstract: An herbal extract which induces immune cells to produce interferon and activates Toll-like receptors and a preparation method thereof are provided. The herbal extract is extracted from an effective amount of raw material including Glycyrrhizae Radix, Bupleuri Radix, Scutellariae Radix, Schisandrae Fructus and Paeoniae Rubra Radix. Glycyrrhizae Radix, Bupleuri Radix, Scutellariae Radix, Schisandrae Fructus and Paeoniae Rubra Radix have a weight ratio of 1-5:1-5:1-5:1-3:1-3.

Abstract: Methods of extracting from a part of a variety of the species Aristolochia Longa pomer a biologically active extract are disclosed. Methods of reducing cell growth in a subject and inducing apoptosis in a cell are also disclosed.

Abstract: A method of using guava extract is disclosed that includes administering alcohol to a mammal, and administering guava extract within no greater than about 12 hours of administering of the alcohol. A composition is also disclosed that includes a pharmaceutically acceptable carrier and guava extract.

Abstract: The present invention features novel cosmetic skin care compositions for lightening hyperpigmentation.

Abstract: The invention relates to anti-proliferative aqueous extracts derived from plants, the extracts comprising compounds capable of inducing a plant organ into a state of dormancy or maintaining the organ in the state of dormancy. The invention further discloses cosmetic, pharmaceutical and agricultural compositions comprising the anti-proliferative extracts and use thereof.

Abstract: An anti-inflammatory injectable solution is prepared from Symphytum officinale roots by cutting and drying of the vegetal material; calcining it at a temperature of 550-600° C., over a period of 3 to 4 hours; dissolving the ash obtained in distilled water at a ratio of 1:100 to form a solution, the obtained solution is filtered under vacuum, followed by filtration through milipor or semper filters to produce a filtrate and the filtrate is subjected to boiling evaporation to produce a liquid having a viscosity of 6.57±0.5 cP; and then drying a thin layer of the liquid so producedat a temperature of 200-250° C., over a period of 5-15 minutes until a white powder is obtained; and thereafter dissolving said white powder in distilled water in amount of 1 to 700 mg to 100 ml distilled water or saline solution.

Abstract: An antifungal composition and penetrating carrier system for topical treatment of dermatophytic infection and secondary bacterial infections. The antifungal composition includes various fungistatic and fungicidal essential oil components, or combinations thereof. The penetrating carrier system may include various ingredients, including a penetration enhancer, such as isopropyl myristate.

Abstract: The invention relates to plant extracts, especially based on species of the genus Agapanthus and combinations thereof with other extracts deriving from other plants. The invention further relates to the isolation, purification and identification of compounds in these extracts. The plant extracts and the isolated substances show significant antimicrobial activity, especially antifungal activity, and bio-stimulatory efficacy, when applied to other plants in vitro and in vivo, including under field conditions. The products according to this invention are suitable to be used as plant protecting agents for many crops and economic plants as an alternative for chemical pesticides.

Abstract: Onions (Allium Cepa and its close relatives, as opposed to Allium Sativum) contain potent coagulation modulators, as well as platelet inhibitors. Clinical, in vivo and in vitro testing confirms that the efficacy of commonly consumed quantities of onions in terms of the efficacy of its impact on coagulation and platelet function rivals and in many respects exceeds the potency of any other modalities available today. Additionally, onion compounds have unique effects as described later in this application.

Abstract: The present invention relates to a use of a crude extract, non-polar solvent soluble extract or purified extract of the hardy kiwifruit for the preparation of therapeutic agent for treating and preventing baldness disorder and seborrheic skin disease in human and mammal, and health care food, food additives, feed additives, cosmetic composition comprising the same. The hardy kiwifruit reduced blood DHT level, promoted the formation of hair root in mouse model experiment, and inhibited the failing out of hair and improved seborrheic skin disease of volunteers such as keratigenous skin, seborrhea etc.

Abstract: A method for obtaining an immune response to a non-enteric pathogen antigen (NEPA) such as hepatitis B surface antigen (HBsAg) by feeding the antigen in a plant material to an animal that is immunoreceptive to the NEPA. It has now been discovered that the animal may be made immunoreceptive to the NEPA such as HBsAg by prior primary immunization. When the animal is made immunoreceptive by a prior, e.g. primary, immunization, an immune response to the NEPA may be boosted in the animal by feeding the animal the plant material containing the NEPA. For example, an animal, e.g. a human, that previously had a positive response to primary immunization against hepatitis B, can have a booster response to HBsAg by feeding the animal the antigen in a plant material. The plant material is a substance comprising a physiologically acceptable plant material, especially potatoes, containing the NEPA, e.g. hepatitis B surface antigen (HBsAg). The NEPA, e.g.

Abstract: A method and composition made from extraction of the roots of Cissus Quadrangularis Linn plant is disclosed. The method comprises washing, drying and grinding the roots to provide a powdered root. A first solvent is added to the powdered root to extract a mixture comprising one or more keto-steroids and impurities. A second solvent is added to the mixture of the partially extracted powdered root and first solvent, wherein the one or more keto-steroids is substantially soluble in the second solvent and the impurities are soluble in the first solvent. A highly purified composition obtained by the method may be further combined with at least one excipient to provide a high yield keto-sterone composition having a predetermined keto-sterone content. A dose of the keto-sterone composition may be administered to a person to promote lean body mass, treat damaged or diseased connective tissue and provide an analgesic effect while reducing cortisol.

Abstract: The present inventions relates to a vegetabilic, preferably potato, fiber preparation and fractions thereof for use as a supplement, a functional food, a functional mix, a pro health product and a pharmaceutical composition; it further relates to a food additive, and a food product, a feed additive and a feed product, a beverage, a supplement, a functional mix, a functional food, a health food and a pharmaceutical composition for inhibition of the effects of a dietary carcinogenic substance in humans and animals; and for inhibition of the development of neoplasma upon exposure of a human or animal for a dietary carcinogenic substance. Further it relates to a medicament, and its uses for the manufacture of a medicament for inhibition of the effects of a dietary carcinogenic substance in humans and animals; and for inhibition of the development of neoplasma upon exposure of a human or animal for a dietary carcinogenic substance.

Abstract: The present invention relates to compositions for enhancing fertility in a male individual comprising extracts of radish seeds, celery seeds, black seeds and ginger rhizome, methods of enhancing fertility in a male individual comprising the step of administering said composition, and the use of said composition as a medicament.